Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Related Experiment Video
Updated: Jun 28, 2026

13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Kevin O Saunders1,2,3,4, Norbert Pardi5, Robert Parks6,7
1Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
NPJ Vaccines
|November 7, 2021
Abstract
No abstract available in PubMed .
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022